Status:
COMPLETED
Genotype Information and Functional Testing Study
Lead Sponsor:
Scripps Health
Collaborating Sponsors:
Bristol-Myers Squibb
Sanofi
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
This study is a sub-study of GRAVITAS (clinicaltrials.gov identifier NCT00645918). The purpose of this study is to assess which genes influence residual platelet reactivity on standard dose clopidogre...
Detailed Description
AS DESCRIBED BY THE PI: This study is a sub-study of GRAVITAS (clinicaltrials.gov identifier NCT00645918). The purpose of this study is to assess which genes influence residual platelet reactivity on ...
Eligibility Criteria
Inclusion
- Patients meeting inclusion criteria for GRAVITAS who undergo VerifyNow blood sampling for VerifyNow P2Y12 platelet function testing and IVRS entry for GRAVITAS randomization/selection determination
Exclusion
- See GRAVITAS trial (ClinicalTrials.gov identifier: NCT00645918)
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2010
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00992420
Start Date
October 1 2009
End Date
August 31 2010
Last Update
November 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scripps Genomic Medicine
La Jolla, California, United States, 92037